Rathbones Group PLC Moderna, Inc. Transaction History

Rathbones Group PLC

$19 Billion
Q3 2024

A detailed history of Rathbones Group PLC transactions in Moderna, Inc. stock. As of the latest transaction made, Rathbones Group PLC holds 10,974 shares of MRNA stock, worth $436,435. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,974

Previous 12,728 13.78%

Holding current value

$436,435

Previous $1.51 Million 51.49%

% of portfolio

0.0%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$63.64 - $125.14 $111,624 - $219,495	-1,754 Reduced 13.78%	10,974 $733,000
Q2 2024 Aug 09, 2024	BUY	$101.21 - $166.61 $10,121 - $16,661	100 Added 0.79%	12,728 $1.51 Million
Q1 2024 May 14, 2024	BUY	$85.37 - $115.44 $147,433 - $199,364	1,727 Added 15.84%	12,628 $1.35 Million
Q4 2023 Feb 13, 2024	BUY	$69.51 - $104.43 $95,298 - $143,173	1,371 Added 14.39%	10,901 $1.08 Million
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $495,450 - $650,648	5,139 Added 117.03%	9,530 $984,000
Q2 2023 Aug 04, 2023	BUY	$118.5 - $160.53 $15,405 - $20,868	130 Added 3.05%	4,391 $533,000
Q1 2023 May 12, 2023	SELL	$135.66 - $197.02 $17,635 - $25,612	-130 Reduced 2.96%	4,261 $654,000
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $74,461 - $132,115	629 Added 16.72%	4,391 $788,000
Q3 2022 Nov 03, 2022	SELL	$118.07 - $194.18 $11,807 - $19,418	-100 Reduced 2.59%	3,762 $445,000
Q2 2022 Aug 12, 2022	BUY	$117.13 - $176.59 $53,762 - $81,054	459 Added 13.49%	3,862 $552,000
Q1 2022 May 11, 2022	BUY	$126.46 - $235.05 $430,343 - $799,875	3,403 New	3,403 $586,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

9.93M

Put Options Held

17.6M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.6B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.

Account

Rathbones Group PLC Moderna, Inc. Transaction History